Glimized-M2 contains a combination of Metformin Hydrochloride Prolonged-release and Glimepiride, which is used to manage Type 2 diabetes mellitus. Metformin is a biguanide that helps reduce blood sugar levels by improving insulin sensitivity and reducing glucose production in the liver. Glimepiride is a sulfonylurea that stimulates the pancreas to release more insulin. Together, they provide effective blood sugar control, helping patients manage diabetes and reduce complications related to high blood sugar levels.
Glimized-M2
Glimized-M2 is used to manage blood sugar levels in patients with Type 2 diabetes by combining Metformin and Glimepiride.
Description
Reviews (0)
FAQ
Glimized-M2 is used to manage blood sugar levels in patients with Type 2 diabetes by combining Metformin and Glimepiride.
Metformin reduces liver glucose production and improves the body's sensitivity to insulin, helping lower blood sugar levels.
Glimepiride stimulates the pancreas to produce more insulin, helping control blood sugar levels after meals.
It is usually taken once daily with meals, but follow your healthcare provider's instructions for best results.
Some common side effects include low blood sugar (hypoglycemia), nausea, dizziness, and gastrointestinal upset. Always consult a doctor if symptoms persist.
Reviews
There are no reviews yet.